Estrella Immunopharma, Inc. (ESLA) Insider Trading

Name: Estrella Immunopharma, Inc. (ESLA) insider trading: SEC Form 4 filings
Creator: Insiders Notifier
License: https://www.sec.gov/privacy#dissemination

Latest Form 4 (Aug 26, 2026): Liu Cheng (CEO): Exercise/Conversion of 100,000 shares, $81.5K.

Get alerted when insiders trade ESLA

Email address

Loading company data...

Beta

Loading company details...

Beta